Civica Rx Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • Civica Rx's estimated annual revenue is currently $22.1M per year.(i)
  • Civica Rx's estimated revenue per employee is $201,000

Employee Data

  • Civica Rx has 110 Employees.(i)
  • Civica Rx grew their employee count by 38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Civica Rx (the initiative previously known as Project Rx) is a new not-for-profit generic drug company that will help patients by addressing shortages and high prices of lifesaving generic medications. Initial governing members of Civica Rx will include Catholic Health Initiatives, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health. These seven organizations, representing about 500 U.S. hospitals, will each provide leadership for the Civica Rx Board of Directors and will provide much of the initial capitalization for the company. The U.S. Department of Veterans Affairs (VA) will also work in consultation with Civica Rx to address its particular needs. Three major philanthropies will also join Civica Rx as governing members: the Laura and John Arnold Foundation, the Peterson Center on Healthcare, and the Gary and Mary West Foundation. The engagement of philanthropic members is intended to further support and safeguard the company’s not-for-profit, social welfare mission.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Civica Rx News

2022-04-20 - Civica to produce lower-cost insulin

Civica Rx, a nonprofit generic drug-maker with a pharmaceutical manufacturing plant under construction in Petersburg, plans to produce three...

2022-04-13 - Drugmakers’ copay coupons are pushing up drug prices - not curbing them: Kelly O’Reilly

The Civica Rx team, hospital leaders and elected officials help dedicate new offices in April. In this April 19, 2019 file photo, the Civica Rx...

2022-03-22 - Insulin has been around for 100 years, so why is it still so ...

Martin VanTrieste is president and CEO of Civica Rx. The high cost of insulin in the U.S., where some people with diabetes pay hundreds or even...

2020-10-05 - The U.S. needs to support American-made medicines

Two years ago, a group of U.S. hospitals launched Civica Rx, a nonprofit generic drug company that I have the honor to lead. Its core mission is to deliver quality medicines at sustainable prices. From the very start, part of Civica’s approach has included an emphasis whenever possible on Ameri ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding